The Prognostic Significance of Global Aberrant Alternative Splicing in Patients With Myelodysplastic Syndrome

Blood Cancer Journal - United States
doi 10.1038/s41408-018-0115-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Significance of Monosomal Karyotype in Myelodysplastic Syndrome: A Meta-Analysis

Hematology
Hematology
2018English

Prognostic Markers of Efficiency of Immunosupressive Therapy in Patients With Myelodysplastic Syndrome

ScienceRise
2015English

The Prognostic Significance of Chromosome 17 Abnormalities in Patients With Myelodysplastic Syndrome Treated With 5‐azacytidine: Results From the Hellenic 5‐azacytidine Registry

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Profiling of Prognostic Alternative Splicing in Melanoma

Oncology Letters
Cancer ResearchOncology
2019English

Aberrant Expression of the Long Non-Coding RNA GHRLOS and Its Prognostic Significance in Patients With Colorectal Cancer

Journal of Cancer
Oncology
2017English

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients With Primary Myelodysplastic Syndrome

PLoS ONE
Multidisciplinary
2016English

Improving Prognostic Tools for Patients With Myelodysplastic Syndromes

Mayo Clinic Proceedings
Medicine
2018English

Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy